Sign in

Arun Sarin

Director at SCHWAB CHARLESSCHWAB CHARLES
Board

About Arun Sarin

Arun Sarin, age 70 at the 2025 annual meeting, has served as an independent director of The Charles Schwab Corporation since 2009. He sits on the Nominating & Corporate Governance Committee and the Risk Committee, bringing deep public company leadership experience as former CEO of Vodafone and President/COO of AirTouch, and currently serves as lead independent director at Accenture plc and a director at Cerence Inc.

Past Roles

OrganizationRoleTenureCommittees/Impact
Vodafone Group PlcChief Executive Officer2003–2008Led global telecom operations; public company CEO experience
AirTouch Communications, Inc.President & Chief Operating OfficerAppointed 1997Senior operator in wireless telecom
Vodafone (US/Asia-Pacific)CEO, US/Asia-Pacific regionAppointed 1999Regional CEO experience
Infospace, Inc.Chief Executive Officer2000–2001Technology operator/CEO
Accel-KKR TelecomChief Executive Officer2002–2003PE-backed telecom leadership
Court of the Bank of EnglandNon-executive director2005–2009Central bank governance experience
Trepont Acquisition Corp I (SPAC)Chairman of the Board2020–2022Capital markets/SPAC oversight

External Roles

OrganizationRoleTenureNotable Responsibilities
Accenture plc (NYSE: ACN)Lead Independent Director; DirectorLead independent since Feb 2025; director since 2015Board leadership; governance oversight
Cerence Inc. (Nasdaq: CRNC)Director; Chairman (until Feb 2025)Director since 2019; Chair 2019–Feb 2025Automotive software board leadership
Ola Electric Mobility Ltd.DirectorSince 2019EV industry exposure
Cisco Systems, Inc.Director (prior)2009–2020Large-cap tech governance
Safeway, Inc.Director (prior)2009–2015Consumer/retail exposure
Blackhawk Network Holdings, Inc.Director (prior)2009–2018Payments and incentives

Board Governance

  • Independence: The board determined Sarin is independent under NYSE standards; only Charles R. Schwab, Walter W. Bettinger II, Richard A. Wurster, and Carolyn Schwab-Pomerantz are non-independent. Notably, Sarin serves as a director of a consulting firm to which the company has made payments; these transactions are in the ordinary course and on market terms per related-party policy. Independence maintained.
  • Committees: Member—Nominating & Corporate Governance (ESG oversight, succession planning, board assessments) and Risk (enterprise risk framework, capital/liquidity, cybersecurity).
  • Attendance: Board held 8 meetings in 2024; all directors attended at least 75% of applicable meetings.
  • Executive sessions: Non-management directors meet regularly; independent directors meet at least annually, presided over by the Nominating & Corporate Governance Chair.
  • Board structure: Four standing committees; all chaired by independent directors, with Audit, Compensation, and NCG composed entirely of independent directors.

Fixed Compensation

  • Structure: Non-employee director annual cash retainer $100,000; Audit and Risk Committee Chair retainer $50,000; Audit and Risk Committee member retainer $20,000; Compensation and NCG Committee Chair retainer $50,000; Compensation and NCG Committee member retainer $15,000. No meeting fees.
  • 2024 Annual Equity Grant: $215,000 value (60% RSUs, 40% stock options); grants on second business day after annual meeting; RSUs/options vest over 3 years (25%, 25%, 50%); options expire 10 years; standard termination provisions.
Component2024 Amount (USD)Notes
Cash retainer and committee fees$135,000 Based on committee service (Risk and NCG member)
Stock awards (RSUs) – grant date fair value$129,027 Annual director grant under 2022 SIP
Option awards – grant date fair value$86,008 Annual director grant under 2022 SIP
Total$350,035 Sum of cash + RSU + options
  • Deferred Compensation: Directors may defer retainers into RSUs or options via the DCP2; Sarin did not defer retainers in 2024.

Performance Compensation

  • Director equity awards are time-based (no performance metrics). The company’s practice prohibits timing equity grants around MNPI; option exercise price equals closing price on grant date.
Award DetailSarin PositionVesting/Terms
Outstanding stock options (as of 12/31/2024)63,010 options Annual grants; 10-year expiry; 4-year graded vesting for options granted under plan; no RSUs vest within 60 days of 3/3/2025
Outstanding RSUs (as of 12/31/2024)4,708 RSUs 3-year vesting schedule; no RSUs convertible within 60 days of 3/3/2025

Other Directorships & Interlocks

CompanyRelationship to SCHWPotential Interlock/Conflict Notes
Consulting firm (unnamed) where Sarin is a directorCompany has made payments for consulting servicesOrdinary-course transactions; independence maintained; governed by Related Party Transactions Policy
Accenture, Cerence, Cisco, Safeway, BlackhawkRoutine vendor/customer relationships not disclosed specific to SarinCompany engages with large asset managers and tech providers in ordinary course; related-party policy applies broadly

Expertise & Qualifications

  • Public company executive and board experience; strategic planning; finance; business operations; information technology/cybersecurity; risk management; international business; ESG oversight.
  • Telecom and technology domain expertise from Vodafone/AirTouch; governance credentials from central bank service.

Equity Ownership

MetricValue
Shares owned23,113
Right to acquire within 60 days (options/RSUs)45,167
Total beneficial ownership68,280
Ownership as % outstanding<1% (less than 1%)
Director ownership guideline$400,000 required; 5-year compliance window; RSUs count; options do not
Compliance status (as of 12/31/2024)All directors complied
Pledging/HedgingProhibited under Insider Trading Policy

Governance Assessment

  • Board effectiveness: Sarin’s dual committee roles (Risk; NCG) align with SCHW’s core oversight areas—enterprise risk, capital/liquidity, cybersecurity, ESG, succession—supporting investor confidence in governance discipline.
  • Independence and engagement: Independent under NYSE rules with at least 75% meeting attendance; serves in roles that regularly hold executive sessions led by the NCG Chair, promoting independent oversight.
  • Ownership alignment: Complies with robust $400k director ownership guideline; material director equity exposure via RSUs/options; pledging/hedging prohibited, reducing alignment risk.
  • Compensation structure: Balanced cash/equity mix ($350,035 total in 2024) with multi-year vesting, no meeting fees, and optional deferral; consistent with market and overseen by independent Compensation Committee with external advisor, supporting pay-for-governance alignment.
  • Potential conflicts—monitoring: Payments to a consulting firm where Sarin is a director are flagged in independence review; transactions subject to Audit Committee policy and ordinary-course terms, mitigating conflict risk though worth ongoing monitoring.
  • Broader signals: 2024 say-on-pay passed with ~91% support, indicating positive shareholder sentiment on compensation governance across SCHW; overall risk oversight framework is mature with independent committee chairs.

RED FLAGS: Related-party exposure via consulting firm payments requires continued scrutiny for materiality and terms, though independence is affirmed and policy controls are in place. No pledging/hedging permitted; no attendance or delinquent reporting issues disclosed for Sarin.